secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lexaria Bioscience Corp. (LEXX)
CIK:        0001348362
Form:       8-K
Filed at:   2025-09-25T23:59:59+00:00
Accession:  0001640334-25-001717
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Lexaria Bioscience terminates $5M equity distribution agreement with JonesTrading
--------------------------------------------------------------------------------

- Terminated Capital on Demand Sales Agreement with JonesTrading effective September 19, 2025.
- Agreement allowed up to $5M in common stock; only 14,995 shares sold for $38,236 gross proceeds.
- Original agreement dated Aug 21, 2024; amended Feb 5, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1348362/000164033425001717/0001640334-25-001717-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1348362/000164033425001717/lxrp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-25-001717

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer